IL127464A0 - Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders - Google Patents

Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders

Info

Publication number
IL127464A0
IL127464A0 IL12746497A IL12746497A IL127464A0 IL 127464 A0 IL127464 A0 IL 127464A0 IL 12746497 A IL12746497 A IL 12746497A IL 12746497 A IL12746497 A IL 12746497A IL 127464 A0 IL127464 A0 IL 127464A0
Authority
IL
Israel
Prior art keywords
treatment
acetic acid
acid derivatives
thrombotic disorders
piperidine acetic
Prior art date
Application number
IL12746497A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9613018.2A external-priority patent/GB9613018D0/en
Priority claimed from GBGB9613095.0A external-priority patent/GB9613095D0/en
Priority claimed from GBGB9613017.4A external-priority patent/GB9613017D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL127464A0 publication Critical patent/IL127464A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL12746497A 1996-06-21 1997-06-19 Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders IL127464A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9613018.2A GB9613018D0 (en) 1996-06-21 1996-06-21 Therapeutic indazoles
GBGB9613095.0A GB9613095D0 (en) 1996-06-21 1996-06-21 Therapeutic piperidines
GBGB9613017.4A GB9613017D0 (en) 1996-06-21 1996-06-21 Therapeutic compounds
PCT/EP1997/003196 WO1997049699A1 (en) 1996-06-21 1997-06-19 Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders

Publications (1)

Publication Number Publication Date
IL127464A0 true IL127464A0 (en) 1999-10-28

Family

ID=27268341

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12746497A IL127464A0 (en) 1996-06-21 1997-06-19 Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders

Country Status (17)

Country Link
EP (1) EP0912555A1 (tr)
JP (1) JP2000512648A (tr)
KR (1) KR20000022041A (tr)
AP (1) AP9801417A0 (tr)
AR (1) AR008245A1 (tr)
AU (1) AU3261197A (tr)
BR (1) BR9709930A (tr)
CA (1) CA2258753A1 (tr)
CZ (1) CZ424698A3 (tr)
EA (1) EA199801015A1 (tr)
ID (1) ID17052A (tr)
IL (1) IL127464A0 (tr)
IS (1) IS4924A (tr)
NO (1) NO985974L (tr)
PL (1) PL330797A1 (tr)
TR (1) TR199802665T2 (tr)
WO (1) WO1997049699A1 (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7642278B2 (en) 2001-07-03 2010-01-05 Novartis Vaccines And Diagnostics, Inc. Indazole benzimidazole compounds
EP1401831A1 (en) 2001-07-03 2004-03-31 Chiron Corporation Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors
TW200401641A (en) 2002-07-18 2004-02-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands
RU2347780C2 (ru) * 2003-02-14 2009-02-27 Уайт Гетероциклил-3-сульфонилиндазолы в качестве лигандов 5-гидрокситриптамина-6
AU2007235499A1 (en) 2006-04-05 2007-10-18 Wyeth Sulfonyl-3-heterocyclylindazole derivatives as 5-hydroxytryptamine-6 ligands
JP5208963B2 (ja) 2007-01-10 2013-06-12 エフ．ホフマン−ラ ロシュ アーゲー キマーゼ阻害剤としてのスルホンアミド誘導体
CN113655155A (zh) * 2021-07-28 2021-11-16 任贤金 一种测定sph3127有关物质的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4124942A1 (de) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0612313A1 (en) * 1991-11-14 1994-08-31 Glaxo Group Limited Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
GB9208740D0 (en) * 1992-04-23 1992-06-10 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
NO985974L (no) 1999-02-17
ID17052A (id) 1997-12-04
IS4924A (is) 1998-12-15
JP2000512648A (ja) 2000-09-26
CZ424698A3 (cs) 1999-05-12
TR199802665T2 (tr) 1999-03-22
AP9801417A0 (en) 1998-12-31
PL330797A1 (en) 1999-06-07
BR9709930A (pt) 1999-08-10
CA2258753A1 (en) 1997-12-31
AR008245A1 (es) 1999-12-29
EA199801015A1 (ru) 1999-08-26
EP0912555A1 (en) 1999-05-06
WO1997049699A1 (en) 1997-12-31
NO985974D0 (no) 1998-12-18
AU3261197A (en) 1998-01-14
KR20000022041A (ko) 2000-04-25

Similar Documents

Publication Publication Date Title
AU3339897A (en) Sulphonamide derivatives and their use in the treatment of cns disorders
GR980300033T1 (en) Compositions for the treatment of dermatological disorders and methods for their use
AU3725997A (en) S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
AU3102097A (en) Spiro-piperidine derivatives and their use as therapeutic agents
PL327610A1 (en) Quinoline and quinozoline compounds useful in therapy
AU6566094A (en) Heterocyclic derivatives in the treatment of ischaemia and related diseases
AU4171500A (en) Flupirtine in the treatment of fibromyalgia and related conditions
ZA979175B (en) Novel piperidineketocarboxylic acid derivatives their preparation and use
AU4342989A (en) Mercapto-acylamino acids useful in the treatment of cardiovascular disorders and as analgesics
IL126476A0 (en) Aminoisoquinolines and aminothienopyridine derivatives and their use as anti-inflammatory agents
ZA973097B (en) Novel aspire-hydroxy acid derivatives their preparation and use
GB9507415D0 (en) Production and uses of caffeic acid and derivatives thereof
AU2058697A (en) Treatment of sleep disorders
AU3099997A (en) The use of tcet in the prophylaxis and treatment of allergies
ZA973098B (en) Novel carboxylic acid derivatives their preparation and use
AU3261097A (en) Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders
ZA973096B (en) Novel carboxylic acid derivatives their preparation and use
SG63774A1 (en) Improvements in or relating to the monitoring of people
IL127464A0 (en) Piperidine acetic acid derivatives and their use in the treatment of thrombotic disorders
AU3268197A (en) Spiro-piperidine derivatives and their use as therapeutic agents
IL131666A0 (en) Novel carboxylic acid derivatives their preparation and use in treating cancer
AU3114295A (en) Methods of prognosing the course and degree of dementia in patients with beta-amyloid-related diseases
AU6281298A (en) Use of lofexidine in the treatment of behavioral disorders
AU4569993A (en) Bile acid derivative and use thereof in therapy
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory